Next Article in Journal
Long-Term Follow-Up of Vestibular Function in Cochlear-Implanted Teenagers and Young Adults
Previous Article in Journal
Exploring the Influence of Online Price Anchoring and Attribute Framing on the Likelihood of Hearing Aid Purchases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances

by
Aniket A. Saoji
1,*,
Madison K. Graham
1,
Melissa D. DeJong
1,
Joscelyn R. K. Martin
1,
Joerg Pesch
2 and
Filiep J. Vanpoucke
2
1
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN 55905, USA
2
Cochlear Ltd., Advanced Innovation, 2800 Mechelen, Belgium
*
Author to whom correspondence should be addressed.
Audiol. Res. 2025, 15(2), 41; https://doi.org/10.3390/audiolres15020041
Submission received: 20 February 2025 / Revised: 30 March 2025 / Accepted: 7 April 2025 / Published: 12 April 2025

Abstract

:
Background/Objectives: Electrode impedance is crucial for optimizing cochlear implant (CI) stimulation and hearing outcomes. While typically stable, some patients experience unexplained impedance fluctuations. This study used electrode impedance subcomponent analysis to identify the subcomponents contributing to these impedance fluctuations. Methods: This study analyzed clinical electrode impedances and transimpedance matrix (TIM) measurements in 10 CI patients with Nucleus devices (CI422, CI522, or CI622 electrode arrays) who exhibited fluctuating or rising electrode impedances. TIM measurements used a cathodic-leading biphasic pulse (110 CLs, 75 µs/phase, 7 µs interphase interval). Electrode impedances were determined at 6, 12, 18, 24, and 75 µs, and subcomponents (access resistance [near-field/far-field] and polarization impedance [Warburg capacitance/Faraday resistance]) were calculated. Results: Both access resistance and polarization impedance changes contributed to impedance fluctuations. Large changes in near-field resistance compared to far-field resistance were associated with increased resistance to current flow closer to the surface of the electrode. The decreased double-layer capacitance and slightly increased Faraday resistance further suggested increased resistance to charge transfer at the electrode–electrolyte interface. Conclusions: Electrode impedance subcomponent analysis reveals changes in the electrochemical reaction at the electrode surface that cause fluctuating or rising CI electrode impedances.

1. Introduction

In cochlear implants (CIs), electrode impedance measurement plays a role in optimizing power requirements, establishing electrode integrity, and determining electrical stimulation parameters such as the pulse duration, pulse amplitude, and stimulation rate. During the measurement of electrode impedances, a biphasic pulse with a current (I) is delivered to the stimulating electrode, and the voltage (V) generated is measured. The electrode impedance is calculated by dividing the measured voltage V by the current amplitude I. The electrode impedance derived from the voltage measured at the end of the leading phase of the biphasic pulse is known to reflect the total electrode impedance, which is a combination of the tissue impedance and electrode contact impedance. The increase in stimulation voltage measured at the onset of the biphasic pulse is known as the access voltage (Va). The difference between the total voltage (VT) measured at the end of the first phase of the biphasic pulse and the access voltage is known as the polarization voltage (Vp). The electrode impedances derived from these two voltage (Va and Vp) measurements are known as access resistance (Ra) and polarization impedance (Zp) [1,2,3,4,5,6,7].
In monopolar mode, Ra represents the resistance to current flow between the intracochlear electrode and the extracochlear ground or return electrode. Ra is the sum of near-field resistance (Rn) and far-field resistance (Rf) connected in series. Rn represents the resistance to current flow through the wire connecting the implant to the electrode, the platinum electrode, the electrode–electrolyte interface, and the very close vicinity of the electrode contact. Rn can monitor localized changes on the electrode surface and the electrode–electrolyte interface. Rf represents the resistance to current flow through the cochlear structures and surrounding extracochlear tissue. Polarization impedance (Zp) is modellable by a simplified electrical circuit consisting of Warburg impedance (Cp) and Faradaic resistance (Rp). Cp reflects the double-layer capacitance formed by the accumulation of positive ions in the perilymph against the negatively charged platinum electrode or vice versa. This process is reversible by involving the non-Faradaic charge injection without electron transfer. Rp models the charge transfer reactions that become active upon the sufficient charging of the double layer. These reactions involve electron exchange between the platinum electrode and the perilymph electrolytes. Electrode impedance subcomponent analysis can be defined using the following formulas:
Total impedance (ZT) = access resistance (Ra) + polarization impedance (Zp)
Ra = near-field (Rn) + far-field (Rf) resistance
Zp = Warburg capacitance (Cp) and Faradaic resistance (Rp)
During programming visits, repeated clinical electrode impedance measurements show high re-test reliability with a median difference of 123 Ω [8,9]. Choi et al. suggested that a median increase in electrode impedance ≥4 kΩ should be considered significant and may reflect changes in the protein composition and cell contents of the inner-ear fluids [9]. Clinical electrode impedances have been shown to vary with the inflammation of the inner ear [9,10], presence of middle-ear fluid [11], loss of residual hearing [12,13], and introduction of new medical conditions or medications. Neuburger et al. attributed changes in clinical electrode impedances to exceeding voltage compliance with electrical stimulation delivery [14]. Both steroid prescriptions and modifications to electrical stimulation parameters (i.e., widening pulse duration) have shown impedance stabilization [14,15].
A small subset of patients exhibits persistent variations in clinical electrode impedances following treatment, even in the absence of identifiable or well-understood underlying causes. In two CI patients with fluctuating electrode impedances, Saoji et al. found that electrical stimulation increased electrode impedance, and device rest decreased it [16]. The mechanism behind this increase in impedance after electrical stimulation remains unclear. We observed that rising electrode impedances are not always persistent; an electrode might show increased impedance one day and be stable the next day. This impedance rise is localized and electrode-specific, triggered by electrical stimulation on individual electrodes, without affecting neighboring ones. Notably, disabled electrodes do not exhibit this increase. Patients with this fluctuating impedance pattern often report significant volume variations and poor sound quality, leading to increased clinic visits. To manage these issues, we have implemented device rest as a strategy. This includes periods of complete device rest or the use of alternating programs where either even or odd electrodes are disabled. By cycling between these programs, we provide targeted rest to specific electrodes, which has demonstrated improvements in sound quality for these patients.
The mechanism behind fluctuating or rising electrode impedances is not fully understood. However, impedance subcomponent analysis offers a valuable tool to investigate these fluctuations by distinguishing between near- and far-field changes within the cochlea. The ability to lower impedance through device rest offers a valuable opportunity to investigate total electrode impedance and its components in these patients.
This exploratory study utilized electrode impedance subcomponent analysis in 10 Nucleus CI recipients exhibiting unexplained electrode impedance fluctuations without apparent middle- or inner-ear pathology. The aim was to determine if electrode impedance subcomponent analysis could identify specific impedance subcomponents associated with these fluctuations.

2. Methods

A retrospective analysis of clinical electrode impedances and transimpedance matrix measurements performed during routine clinical visits is reported for 10 Nucleus CI patients with fluctuating or rising electrode impedances. Approximately 5% of our patient population experiences persistent electrode impedance fluctuations. While transient fluctuations are common, typically over time, this subset of patients demonstrated fluctuations throughout the duration of implant use. Table 1 shows the subject demographics, the device type, implant duration, disabled electrodes, and the timing of clinical visits (from the day of implantation) for our study population. Impedance fluctuations were observed in all subjects from their first follow-up visit post-activation. All subjects reported here had the lateral wall electrode array, which is the most preferred electrode type used at our CI center. The study protocol was approved by the Mayo Clinic Institutional Review Board (# 24-010370).
The TransImpedance Matrix (TIM) feature in Custom Sound EP 6.0 software from Cochlear Ltd. (Sydney, Australia) was used to perform these measurements. Electrode voltages were measured at 6, 12, 18, 24, and 75 µs during the cathodic phase of a biphasic pulse (128 µA; 75 µs/phase; 7 µs interphase interval). A biphasic pulse was repeated to measure electrode voltage at each time point throughout the duration of the cathodic phase. The extracochlear case or MP2 electrode was used as the stimulation and recording ground electrode.
For further analysis, the impedance waveforms are described in terms of an equivalent discrete electrical circuit model [1] consisting of a resistor (Ra, access resistance) in series with a parallel circuit consisting of a capacitor (Cp, Warburg capacitance) and a resistor (Rp, Faradaic resistance). The three parameters are extracted from the voltage/impedance waveform by non-linear curve fitting implemented in Matlab (Mathworks, Natick, MA, USA). When recording from a stimulating contact (impedance), the Ra + Cp//Rp circuit model was used. Such a circuit will respond to a biphasic current pulse with a voltage response that is the sum of a voltage pulse (Ra) and a decaying exponential (Cp//Rp).
z ( t ) = v ( t ) I = R a + R p · ( 1 e t / R p · C p )
This total monopolar impedance is time-dependent. The three parameters have a graphical meaning. Ra corresponds to the initial impedance (t = 0 µs). The Rp parameter corresponds to the increase in impedance (polarization) if the pulse width is infinitely long (t = µs) In reality, this maximum polarization will never be obtained because of charge irreversibly leaking away from the contact. A constant phase circuit element (CPE) is more appropriate for long pulse durations. The Cp parameter is inversely proportional to the initial slope of the polarization; e.g., a value Cp = 5-nF implies an initial increase in the total impedance of 200 Ω/µs. This template was matched against the diagonal elements of the TIM recordings. When recording from a non-stimulating contact (off-diagonal elements of the transimpedance matrix), the recording contact is not charged. Therefore, the model was simplified to only the parameter Ra.
The access resistance for all recordings forms a 22 × 22 matrix. The diagonal elements (recording on the stimulating contact) are typically much higher than the off-diagonal elements. Two factors contribute to the peak: first, the voltage in the cochlear duct at the stimulation contact being higher than that on neighboring contacts due to passive conduction (tissue component) because of far-field resistance; second, a local resistive contribution which is part of the interface impedance (near-field Rn). The sum of both is the access resistance. Non-linear curve fitting is used to take into account all non-diagonal recordings for each stimulating electrode [17]. For every stimulation position, a two-sided curve was fitted containing a linear and exponential term:
y = A + B · ( x x 0 ) + C · e x p a b s ( x x 0 ) / D
with different coefficient sets toward the apex and base satisfying a constraint that they share a common intersection point at the stimulation position. This intersection value is taken as the Rf contribution, whereas Rn is defined as its difference from the total Ra value. While this method generally works well, it carries a potential for overestimating the far-field component, particularly at the most basal and apical electrode contacts. The Rf values describe the electrical conduction within the cochlear duct and through the passage to the extracochlear ground electrode. They depend on the anatomy and tissue distribution of the implanted cochlea. The Rn, Cp, and Rp values together constitute the interface impedance. These parameters depend on the geometry of the electrode contact, its surface state, and the electrical conduction properties of the immediate tissue surrounding the electrode contact.

3. Results

3.1. Clinical Impedance Measurements

The clinical impedances were recorded using a pulse duration of 25 µs and pulse amplitude of 78 CLs or approximately 80 µA. Monopolar 1 + Monopolar 2 (MP1 +2) was the return electrode. The results show large changes in electrode impedances for the 10 CI patients across clinical visits. Figure 1 shows the clinical electrode impedances measured using Custom Sound Pro 6.0 clinical programming software for the 10 CI patients. The average impedance of electrodes that decreased after device rest was also plotted, alongside the average impedance of all other electrodes that exhibited fluctuating or increasing impedance across the 10 CI patients. Across 22 electrodes in 10 CI patients, electrode impedance changes ranged from 0.02 kΩ to 16.55 kΩ, with an average of 4.73 kΩ. In five patients (CI2, CI4, CI5, CI7, and CI10), the clinical electrode impedances lowered after 2 or 3 days of device rest. Lowered impedances were plotted at visit V2 for patients CI2, CI5, CI7, and CI10. For patient CI4, lowered impedances were plotted at visit V4. Figure 1 (Average panel) displays the average difference in electrode impedance between five post-device-rest measurements (CI2, CI4, CI5, CI7, CI10) and the overall average across all other measurements for the 10 CI patients. These findings suggest an inverse relationship between electrical stimulation and electrode impedance in the patients who were prescribed device rest. Impedance values decrease during device inactivity (rest) and increase with electrical stimulation [16], which is discussed further in the Discussion Section. The remaining five patients (CI1, CI3, CI6, CI8, and CI9) also showed large fluctuations in clinical electrode impedances. Device rest was not an option for these patients due to their reliance on the implant for daily listening. Given our clinical observations of device rest’s effectiveness in managing fluctuating impedance, it is reasonable to hypothesize that these patients would have exhibited reduced electrode impedances if device rest had been prescribed.

3.2. Transimpedance Matrix Measurements

To investigate the nature of electrode impedance fluctuations, TIM measurements were performed during each clinical visit so that electrode impedances are broken down into constituent components. Figure 2 shows Ra (kΩ) as a function of the 22 intracochlear electrodes for the 10 CI patients. An average access resistance of 7.56 kΩ (SD = 1.86) was measured for the 10 CI patients across multiple clinical visits. Ra was broken down further into near-(Figure 3) and far-field resistance (Figure 4). An average near-field resistance of 5.13 kΩ (SD = 1.74) and far-field resistance of 2.42 kΩ (SD = 0.77) was computed for the 10 CI ears across 26 clinical visits. Visual inspection of the data and the standard deviation calculated show larger changes in near-field resistance contributing to changes in CI electrode impedances across clinical visits. These results are consistent with the notion that changes near the electrode contact area contribute to fluctuating or rising electrode impedances. The resistance of the return path to intracochlear or extracochlear ground (far-field resistance) demonstrated a minimal contribution to the observed increase in electrode impedances.
In five patients (CI2, CI4, CI5, CI7, and CI10) for whom device rest was employed to reduce electrode impedance, the average resistance (Ra) was 5.48 kΩ (SD = 0.8), the near-field resistance was 3.55 kΩ (SD = 0.6), and the far-field resistance was 1.95 kΩ (SD = 0.57) after the rest period. Before device rest, when these patients exhibited fluctuating or increasing impedances, the average Ra was 8.26 kΩ (SD = 1.76), the near-field resistance was 5.64 kΩ (SD = 2.03), and the far-field resistance was 2.29 kΩ (SD = 0.67). These findings suggest a larger change in near-field resistance than in far-field resistance. Polarization impedance was calculated by subtracting the access resistance from total impedance and further divided into Warburg capacitance (Figure 5) and Faraday resistance (Figure 6). Lower capacitance numbers indicate higher polarization impedance. The results show decreasing capacitance with increasing electrode impedances and vice versa. Across 26 clinical visits in the 10 CI ears, the average capacitance was 3.83 nF (SD = 1.89). A strong correlation (r = 0.84) was found between Cp and total electrode impedance at 25 µs, indicating that decreasing capacitance is associated with increasing impedance. For patients CI2, CI4, CI5, CI7, and CI10, the average Cp was 3.27 nF (SD = 1.92), compared to 5.5 nF (SD = 1.6) after device rest resulting in lower electrode impedances.
An average Faraday resistance of 9.47 kΩ (SD = 2.4) was calculated across the 10 CI ears. Interestingly, for CIs 2, 4, 5, 7, and 10, a lower average Faraday resistance of 8.71 kΩ (SD = 1.41) was observed when electrode impedances decreased after device rest compared to 9.6 kΩ (SD = 2.84) when electrode impedances were increasing.

4. Discussion

This study investigated fluctuating or rising electrode impedances in 10 CI ears over multiple clinical visits. Clinical electrode impedance was measured using CI fitting software with a 25 µs cathodic-leading biphasic pulse at 78 CLs. TIM measurements were performed at 6, 12, 18, 24, and 75 µs with a 110 CL pulse. TIM data were then used to analyze impedance subcomponents, as described by [2], to understand the contribution of different subcomponents in fluctuating or rising electrode impedances. In the 10 CI patients, both access resistance and polarization impedance contributed to the observed fluctuations and increases in electrode impedance. Within access resistance, changes were more pronounced in near-field resistance than in far-field resistance. Increased near-field resistance suggests a greater resistance to current flow near the electrode surface, potentially due to alterations in the chemical reactions at the electrode–electrolyte interface [2,3]. This interpretation is supported by the decrease in double-layer capacitance, which indicates increased resistance to charge transfer at the electrode–electrolyte interface [2]. The slight increase in Faraday resistance with rising electrode impedance further supports these findings.
A counterintuitive phenomenon observed is the decrease in electrode impedance in five patients (CI2, CI4, CI5, CI7, and CI10) following a prescribed period of device rest [16]. This contrasts with the typical impedance increase seen with device rest [14]. In these patients, device rest led to decreased impedance, while subsequent electrical stimulation caused a temporary increase in some electrodes. However, the rising impedance trend resumed after stimulation restarted. The mechanism behind this unusual response is unclear and warrants further study. This phenomenon offers a unique opportunity to investigate electrode impedance subcomponents in patients with rising impedance under controlled conditions. Interestingly, disabled electrodes (e.g., electrodes 1–3 in CI5) showed no impedance changes with either device rest or the resumption of stimulation in the other active electrodes. This observation further suggests that electrical stimulation plays a key role in altering the electrochemical reactions at the electrode–electrolyte interface and that localized changes alone in the cochlear environment or the electrolyte near the surface of the electrode cannot explain the rising or fluctuating electrode impedances.
The accurate assessment of electrode impedance in CIs necessitates measuring the total electrode impedance. This measurement is typically taken at the end of the first phase in a biphasic pulse, using the same pulse duration employed for electrical stimulation on that specific electrode. In contrast, relying solely on access resistance as a proxy for electrode impedance can lead to the underestimation of the total current flow resistance within the cochlea. Access resistance is measured either at the beginning of the first phase or at the end of the second phase of the biphasic pulse. Crucially, this approach neglects the polarization component, which is known to vary depending on the pulse duration. This can result in biphasic current levels exceeding the CI compliance voltage, leading to pulse clipping, which negatively impacts sound quality and speech perception [18].
Also, measuring access resistance only can mask impedance fluctuations entirely or minimize the extent of fluctuations estimated by a clinician. Generally, electrode impedances are assumed to fluctuate between 2 and 4 kΩ across clinical visits [9]. Monitoring electrode impedance fluctuations holds significant clinical value. By analyzing the extent of these fluctuations, clinicians can optimize electrical stimulation parameters, such as pulse duration. The purpose of this optimization is to establish “headroom” that separates comfortable loudness levels (C-levels) from electrode compliance limits. This headroom ensures that even during impedance increases, the delivered biphasic pulses remain unclipped, thereby maintaining an appropriate level of electrical stimulation.
Future research will investigate how targeted electrical stimulation modifications can mitigate or prevent rising impedance. This includes exploring the influence of the pulse duration, stimulation rate, and biphasic pulse polarity on electrode impedance in patients with cochlear implants. Interestingly, some electrodes show temporary impedance increases with stimulation, while their neighbors remain stable. This pattern can reverse on subsequent days, suggesting that impedance fluctuations are caused by local electrochemical reactions closer to the electrode surface offering varying levels of resistance to the flow of current to the cochlear electrolyte.

5. Conclusions

The analysis of electrode impedance subcomponents illuminated the impedance subcomponents contributing to rising or fluctuating electrode impedances. The observed decrease in impedance during device rest provides a unique opportunity to repeatedly measure and analyze subcomponent changes, identifying which components contribute to these impedance variations. This subcomponent analysis suggests that localized changes at the electrode interface, likely related to electrical stimulation and subsequent alterations in the electrochemical reactions at the electrode–electrolyte interface, are responsible for the observed impedance changes.

Author Contributions

Conceptualization, A.A.S. and F.J.V.; methodology, A.A.S., F.J.V. and J.P; formal analysis, A.A.S. and F.J.V.; investigation, A.A.S., M.K.G. and M.D.D.; data curation, A.A.S. and F.J.V.; writing—A.A.S. and F.J.V.; writing—review and editing, A.A.S., M.K.G., M.D.D., J.R.K.M., J.P. and F.J.V. All authors have read and agreed to the published version of the manuscript.

Funding

Internal departmental funding was utilized without commercial sponsorship or support.

Institutional Review Board Statement

This study was approved by the Mayo Clinic Institutional Review Board (24-010370). Approval date: 2024-10-07.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

AAS is a consultant for or has received research support from Sonova AG, Cochlear Americas, and Envoy Medical; JP and FJV are employees of Cochlear Ltd., the manufacturer of the Nucleus cochlear implant. The paper reflects the views of the scientists, and not the company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Vanpoucke, F.J.; Zarowski, A.J.; Peeters, S.A. Identification of the impedance model of an implanted cochlear prosthesis from intracochlear potential measurements. IEEE Trans. Biomed. Eng. 2004, 51, 2174–2183. [Google Scholar] [CrossRef] [PubMed]
  2. Tykocinski, M.; Cohen, L.T.; Cowan, R.S. Measurement and analysis of access resistance and polarization impedance in cochlear implant recipients. Otol. Neurotol. 2005, 26, 948–956. [Google Scholar] [CrossRef] [PubMed]
  3. Newbold, C.; Richardson, R.; Millard, R.; Huang, C.; Milojevic, D.; Shepherd, R.; Cowan, R. Changes in biphasic electrode impedance with protein adsorption and cell growth. J. Neural Eng. 2010, 7, 056011. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  4. Newbold, C.; Mergen, S.; Richardson, R.; Seligman, P.; Millard, R.; Cowan, R.; Shepherd, R. Impedance changes in chronically implanted and stimulated cochlear implant electrodes. Cochlear Implants Int. 2014, 15, 191–199. [Google Scholar] [CrossRef] [PubMed]
  5. Giardina, C.K.; Krause, E.S.; Koka, K.; Fitzpatrick, D.C. Impedance Measures During in vitro Cochlear Implantation Predict Array Positioning. IEEE Trans. Biomed. Eng. 2018, 65, 327–335. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  6. Di Lella, F.A.; De Marco, D.; Fernández, F.; Parreño, M.; Boccio, C.M. In Vivo Real-time Remote Cochlear Implant Capacitive Impedance Measurements: A Glimpse Into the Implanted Inner Ear. Otol. Neurotol. 2019, 40 (Suppl. 5S), S18–S22. [Google Scholar] [CrossRef] [PubMed]
  7. Saoji, A.A.; Graham, M.; Stein, A.; Koka, K. Analysis of electrode impedance and its subcomponents for lateral wall, mid-scala, and perimodiolar electrodes in cochlear implants. Cochlear Implants Int. 2022, 23, 87–94. [Google Scholar] [CrossRef] [PubMed]
  8. Hey, M.; Böhnke, B.; Dillier, N.; Hoppe, U.; Eskilsson, G.; Löwgren, K.; Cullington, H.; Mauch, H.; Müller-Deile, J. The Intra-Cochlear Impedance-Matrix (IIM) test for the Nucleus® cochlear implant. Biomed. Tech. 2015, 60, 123–133. [Google Scholar] [CrossRef] [PubMed]
  9. Choi, J.; Payne, M.R.; Campbell, L.J.; Bester, C.W.; Newbold, C.; Eastwood, H.; O’Leary, S.J. Electrode Impedance Fluctuations as a Biomarker for Inner Ear Pathology After Cochlear Implantation. Otol. Neurotol. 2017, 38, 1433–1439. [Google Scholar] [CrossRef] [PubMed]
  10. Itayem, D.A.; Sladen, D.; Driscoll, C.L.; Neff, B.A.; Beatty, C.W.; Carlson, M.L. Cochlear Implant Associated Labyrinthitis: A Previously Unrecognized Phenomenon with a Distinct Clinical and Electrophysiological Impedance Pattern. Otol. Neurotol. 2017, 38, e445–e450. [Google Scholar] [CrossRef] [PubMed]
  11. Dixon, J.F.; Shinn, J.B.; Adkins, M.; Hardin, B.D.; Bush, M.L. Middle Ear Disease and Cochlear Implant Function: A Case Study. Hear. Balance Commun. 2014, 12, 155–158. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  12. Scheperle, R.A.; Tejani, V.D.; Omtvedt, J.K.; Brown, C.J.; Abbas, P.J.; Hansen, M.R.; Gantz, B.J.; Oleson, J.J.; Ozanne, M.V. Delayed changes in auditory status in cochlear implant users with preserved acoustic hearing. Hear. Res. 2017, 350, 45–57. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Thompson, N.J.; Dillon, M.T.; Buss, E.; Park, L.R.; Pillsbury, H.C., 3rd; O’Connell, B.P.; Brown, K.D. Electrode Array Type and Its Impact on Impedance Fluctuations and Loss of Residual Hearing in Cochlear Implantation. Otol. Neurotol. 2020, 41, 186–191. [Google Scholar] [CrossRef] [PubMed]
  14. Wolfe, J.; Baker, R.S.; Wood, M. Clinical case study review: Steroid-responsive change in electrode impedance. Otol. Neurotol. 2013, 34, 227–232. [Google Scholar] [CrossRef] [PubMed]
  15. Neuburger, J.; Lenarz, T.; Lesinski-Schiedat, A.; Büchner, A. Spontaneous increases in impedance following cochlear implantation: Suspected causes and management. Int. J. Audiol. 2009, 48, 233–239. [Google Scholar] [CrossRef] [PubMed]
  16. Saoji, A.A.; Adkins, W.J.; Olund, A.P.; Graham, M.; Patel, N.S.; Neff, B.A.; Carlson, M.L.; Driscoll, C.L.W. Increase in cochlear implant electrode impedances with the use of electrical stimulation. Int. J. Audiol. 2020, 59, 881–888. [Google Scholar] [CrossRef] [PubMed]
  17. Leblans, M.; Sismono, F.; Vanpoucke, F.; van Dinther, J.; Lerut, B.; Kuhweide, R.; Offeciers, E.; Zarowski, A. Novel Impedance Measures as Biomarker for Intracochlear Fibrosis. Hear. Res. 2022, 426, 108563. [Google Scholar] [CrossRef] [PubMed]
  18. Saoji, A.A.; Adkins, W.J.; Olund, A.P.; Nelson-Bakkum, E.R.; Koka, K. Effect of exceeding compliance voltage on speech perception in cochlear implants. Hear. Res. 2021, 400, 108112. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Electrode impedance measurements during different clinical visits for 10 cochlear implant patients with fluctuating electrode impedances. The abscissa shows electrodes, and the ordinate shows electrode impedance (kΩ).
Figure 1. Electrode impedance measurements during different clinical visits for 10 cochlear implant patients with fluctuating electrode impedances. The abscissa shows electrodes, and the ordinate shows electrode impedance (kΩ).
Audiolres 15 00041 g001
Figure 2. Access resistance calculated from impedance measurements performed at 6, 12, 18, 25, and 75 µs during the first phase of the biphasic pulse in 10 cochlear implant patients.
Figure 2. Access resistance calculated from impedance measurements performed at 6, 12, 18, 25, and 75 µs during the first phase of the biphasic pulse in 10 cochlear implant patients.
Audiolres 15 00041 g002
Figure 3. Near-field resistance in 10 cochlear implant patients with fluctuating impedances.
Figure 3. Near-field resistance in 10 cochlear implant patients with fluctuating impedances.
Audiolres 15 00041 g003
Figure 4. Far-field resistance in 10 cochlear implant patients with fluctuating impedances.
Figure 4. Far-field resistance in 10 cochlear implant patients with fluctuating impedances.
Audiolres 15 00041 g004
Figure 5. Warburg capacitance calculations in 10 CI patients with fluctuating or rising electrode impedances. The bottom middle panel includes calculations for all measured electrode impedances from these patients.
Figure 5. Warburg capacitance calculations in 10 CI patients with fluctuating or rising electrode impedances. The bottom middle panel includes calculations for all measured electrode impedances from these patients.
Audiolres 15 00041 g005
Figure 6. Faraday resistance calculations in patients with fluctuating impedances.
Figure 6. Faraday resistance calculations in patients with fluctuating impedances.
Audiolres 15 00041 g006
Table 1. Subject demographics, implant type, duration of implant use, electrodes disabled, and clinical visit history for the 10 cochlear implant patients with fluctuating or rising electrode impedances.
Table 1. Subject demographics, implant type, duration of implant use, electrodes disabled, and clinical visit history for the 10 cochlear implant patients with fluctuating or rising electrode impedances.
Subject NumberAgeGenderImplant TypeDuration of Implant UseElectrodes DisabledClinical Visits (Days from Cochlear Implantation)
CI164MCI6223 years1, 2 (open)173, 220, 1050
CI269FCI6223 years6 (open)104, 113, 134, 167
CI368MCI5226 yearsNone856, 1675
CI468FCI5226 yearsNone673, 967, 974, 980
CI560FCI6223 years1, 2, 3197, 201, 691
CI686FCI5226 yearsNone951, 1602
CI770MCI4229 years1, 21904, 2042
CI893FCI6223 yearsNone798, 1795
CI969MCI5225 yearsNone1070, 1071
CI1071MCI6222 yearsNone164, 167
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Saoji, A.A.; Graham, M.K.; DeJong, M.D.; Martin, J.R.K.; Pesch, J.; Vanpoucke, F.J. Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances. Audiol. Res. 2025, 15, 41. https://doi.org/10.3390/audiolres15020041

AMA Style

Saoji AA, Graham MK, DeJong MD, Martin JRK, Pesch J, Vanpoucke FJ. Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances. Audiology Research. 2025; 15(2):41. https://doi.org/10.3390/audiolres15020041

Chicago/Turabian Style

Saoji, Aniket A., Madison K. Graham, Melissa D. DeJong, Joscelyn R. K. Martin, Joerg Pesch, and Filiep J. Vanpoucke. 2025. "Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances" Audiology Research 15, no. 2: 41. https://doi.org/10.3390/audiolres15020041

APA Style

Saoji, A. A., Graham, M. K., DeJong, M. D., Martin, J. R. K., Pesch, J., & Vanpoucke, F. J. (2025). Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances. Audiology Research, 15(2), 41. https://doi.org/10.3390/audiolres15020041

Article Metrics

Back to TopTop